XTrend
MenuXTrend

Stock Charts

Charts can help you clearly see the market trend.

DHR

Danaher Corporation

Bid196.67
Ask196.87
Change-2.42
% Chg -1.22%
High200.09
Low196.03

Past performance is not an indication of future results.

About

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians’ offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Industry

Healthcare Equipment & Supplies

Stock Exchange

NYSE

Listing Date

10-12-1969

Trading Specifications
Minimum Price Fluctuation
--
Spreads as low as
--
Average Spreads
--
Minimum Lot Size
--
Commission
--
Trading Hours(GMT+2)
--
Maximum Trading Volume (lots)
--
News
Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow
Stifel maintains Danaher stock Buy rating with $260 target
Danaher stock target raised to $248 by TD Cowen analysts
Barclays lifts Danaher stock price target to $215 on tariff strategy
Danaher stock price target cut to $260 by JPMorgan
Jefferies cuts Danaher stock price target to $230, maintains Buy
Earnings call transcript: Danaher Q1 2025 beats EPS estimates, stock jumps
Danaher Q1 2025 slides reveal mixed results with Biotechnology segment leading growth
Danaher Reports First Quarter 2025 Results
Danaher beats Q1 estimates on top and bottom lines, reaffirms outlook; stock up
XTrend

AFA REGIONAL SPONSOR

XTrendEnglish
XTrend
XTrend
XTrend
XTrend
XTrend